-J Thompson Researcher Activity Profile

Research Author Detailed Information 

J Thompson Publication Rate By Year

J Thompson has published 2 paper(s) in 1949, 1 paper(s) in 1979, 1 paper(s) in 1981, 1 paper(s) in 1986, 1 paper(s) in 1988, 1 paper(s) in 1990, 1 paper(s) in 1995, 1 paper(s) in 2004, 3 paper(s) in 2006, 5 paper(s) in 2007, 3 paper(s) in 2008, for a total of 20 research publications in total.

J J Thompson Author Information

LAST NAME: thompson

FIRST NAME: j

INITIALS: J

AFFILIATION:

Papers

J Thompson's Publication Record

1. Biodegradable estradiol microspheres do not affect uterine involution or characteristics of postpartum estrus in mares. Year Published: 2006
Department of Large Animal Medicine and Surgery, Texas A&M University, College Station, TX 77843 USA.
2. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Year Published: 2006
Molecular Medicine Program, Mayo Clinic, Rochester, MN 55902, USA.
3. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. Year Published: 2007
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. chillard@mcw.edu
4. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. Year Published: 2007
Roche Molecular Diagnostics, 6343, Rotkreuz, Switzerland. Giuseppe.colucci.gc1@roche.com
5. End-of-life decisions in medical practice: a survey of doctors in Victoria (Australia). Year Published: 2007
David A Neil, School of English Literatures, Philosophy and Languages, Faculty of Arts, University of Wollongong, NSW 2522 Australia; http://www.uow.edu.au/arts/staff/selpl.html; dneil@uow.edu.au.
6. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. Year Published: 2007
Roche Molecular Diagnostics, 6343, Rotkreuz, Switzerland. Giuseppe.colucci.gc1@roche.com
7. Radiography of the nasolacrimal passageways. Year Published: 1949
8. Tips on backwashing of ion exchangers. Year Published: 1949
9. End-of-life decisions in medical practice: a survey of doctors in Victoria (Australia). Year Published: 2007
School of English Literatures, Philosophy and Languages, Faculty of Arts, University of Wollongong, NSW 2522 Australia. dneil@uow.edu.au
10. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. Year Published: 1986
11. Radiographic signs of union of scaphoid fractures. An analysis of inter-observer agreement and reproducibility. Year Published: 1988
University Department of Orthopaedic Surgery, Leicester Royal Infirmary, England.
12. Suspected scaphoid fractures. The value of radiographs. Year Published: 1990
Glenfield General Hospital, Leicester, England.
13. Nasopharyngeal nonossifying variant of ossifying fibromyxoid tumor: CT and MR findings. Year Published: 1995
Department of Radiology, University of North Carolina School of Medicine, Chapel Hill 27599-7510, USA.
14. Lateral wall of the olfactory fossa in determining intracranial extension of sinus carcinomas. Year Published: 1979
15. CT approach to benign nasopharyngeal masses. Year Published: 1981
16. Pulmonary venous wedge pressures accurately predict pulmonary arterial pressures in children with single ventricle physiology. Year Published: 2004
Department of Pediatrics, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0130, USA.
17. Metal-on-metal bearings surfaces: materials, manufacture, design, optimization, and alternatives. Year Published: 2006
DePuy International Ltd, Leeds, UK. gisaac@dpygb.jnj.com
18. What can transgenic parasites tell us about the development of Plasmodium-specific immune responses? Year Published: 2008
Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.
19. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Year Published: 2008
1Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN, USA.
20. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Year Published: 2008
Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN 55902, USA.